Bioporto and their patent advisor Høiberg has filed an amended set of claim in regards to the APC-PCI patent application.
The APC-PCI application can be found here.
Its worth noting the conduite that this amendment is expressing, as well as the efford being made to comply with the EPO rules and regulations, as that was direct demand from EPO in the last communication.
I very much hope that this will end in a granted patent, so Bioport will hold both the US and the EU patent.
